| Identification | Back Directory | [Name]
N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide | [CAS]
1130067-18-3 | [Synonyms]
VU0155056
N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide
2-Naphthalenecarboxamide, N-[2-[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-
N-(2-{4-[2-OXO-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOL-1-YL]PIPERIDIN-1-YL}ETHYL)-2-NAPHTHAMIDE;VU0155056 | [Molecular Formula]
C25H26N4O2 | [MDL Number]
MFCD22416857 | [MOL File]
1130067-18-3.mol | [Molecular Weight]
414.5 |
| Hazard Information | Back Directory | [Uses]
VU0155056 has been used as a phospholipase D-1 (PLD1) inhibitor:
- to study its role in regulated exocytosis
- to test bacterial and human PLD enzymes for specificity of inhibition
- in neuro-2a (N2a) cell culture and survival assay
| [Definition]
ChEBI: N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide is a naphthalenecarboxamide. | [Biological Activity]
VU0155056 or N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl ethyl)-2-naphthamide is a cell permeable phospholipase D (PLD) inhibitor. It inhibits both PLD1 and PLD2. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
| Company Name: |
Creative Enzymes
|
| Tel: |
1-516-855-7709 |
| Website: |
www.creative-enzymes.com |
|